Positive EGFR mutation status is a risk of recurrence in pN0–1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis-Reference-Cited by-同舟云学术

Positive EGFR mutation status is a risk of recurrence in pN0–1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis

Published:2020-03 Issue: Volume:141 Page:107-113
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ito Masaoki^ORCID,Miyata Yoshihiro^ORCID,Tsutani Yasuhiro,Ito Hiroyuki,Nakayama Haruhiko,Imai Kentaro,Ikeda Norihiko,Okada Morihito

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Comprehensive molecular profiling of lung adenocarcinoma;Cancer Genome Atlas Research N;Nature.,2014

2. Large-scale screening for somatic mutations in lung cancer;Rosell;Lancet,2016

3. Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients;Wang;Nat. Commun.,2018

4. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII);Midha;Am. J. Cancer Res.,2015

5. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma;Ito;Thorac. Cancer,2018

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection;Cancers;2023-11-30

2. The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study;BMC Cancer;2023-11-14

3. Prognosis of recurrence after complete resection in early-stage lung adenocarcinoma based on molecular alterations: a systematic review and meta-analysis;Scientific Reports;2023-10-31

4. A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer;Cancers;2023-09-14

5. Efficacy of Preoperative Biopsy in Predicting the Newly Proposed Histologic Grade of Resected Lung Adenocarcinoma;Modern Pathology;2023-09